Decrease of carbapenemase-producing Enterobacteriaceae incidence during the first year of the COVID-19 pandemic

J Infect. 2022 Jul;85(1):90-122. doi: 10.1016/j.jinf.2022.03.024. Epub 2022 Apr 1.

Authors

Clarisse Duverger¹, Catherine Monteil², Valérie Souyri², Sandra Fournier²; AP-HP Infection prevention and control teams²

Affiliations

¹ Assistance Publique-Hôpitaux de Paris, Central Infection Prevention and Control Team, 3 avenue Victoria, Paris 75004, France. Electronic address: clarisse.duverger@aphp.fr.
² Assistance Publique-Hôpitaux de Paris, Central Infection Prevention and Control Team, 3 avenue Victoria, Paris 75004, France.

No abstract available

Keywords: COVID-19; Carbapenemase-producing Enterobacteriaceae; Healthcare-associated infection; Infection control; SARS-CoV-2.

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Bacterial Proteins / genetics
COVID-19*
Carbapenem-Resistant Enterobacteriaceae*
Enterobacteriaceae
Enterobacteriaceae Infections* / epidemiology
Humans
Incidence
Microbial Sensitivity Tests
Pandemics / prevention & control
beta-Lactamases

Substances

Anti-Bacterial Agents
Bacterial Proteins
beta-Lactamases